Log in

SPDR S&P Biotech ETF Stock Forecast, Price & News

+1.26 (+1.10 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $116.24
50-Day Range
MA: $110.03
52-Week Range
Now: $116.24
Volume5.94 million shs
Average Volume6.57 million shs
Market Capitalization$6.36 billion
P/E RatioN/A
Dividend Yield0.02%
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Read More

Geographic Exposure of XBI

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI

Basic Details

Issuer SSgA
Fund NameSPDR S&P Biotech ETF
Tax ClassificationRegulated Investment Company
Inception Date1/31/2006
Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotech Index
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$6.39 billion
Average Daily Volume$5.11 million

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Lead Market MakerVirtu Financial
+1.26 (+1.10 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

How has SPDR S&P Biotech ETF's stock price been impacted by COVID-19?

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, XBI stock has increased by 47.1% and is now trading at $116.24.
View which stocks have been most impacted by COVID-19

How often does SPDR S&P Biotech ETF pay dividends? What is the dividend yield for SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF declared a quarterly dividend on Friday, December 20th. Shareholders of record on Monday, December 23rd will be given a dividend of $0.0009 per share on Thursday, December 26th. This represents a $0.00 annualized dividend and a dividend yield of 0.00%. The ex-dividend date of this dividend is Friday, December 20th.
View SPDR S&P Biotech ETF's dividend history

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), Walt Disney (DIS), Micron Technology (MU), AbbVie (ABBV), Cisco Systems (CSCO) and Johnson & Johnson (JNJ).

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the following people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Kellogg W K Foundation Trust (0.48%), Papp L Roy & Associates (0.43%), Whittier Trust Co. (0.41%), Bank of Montreal Can (0.40%), Capital Advisors Inc. OK (0.41%) and American Financial Advisors LLC (0.35%).

Which major investors are selling SPDR S&P Biotech ETF stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including Bank of Nova Scotia, Two Sigma Advisers LP, SG Americas Securities LLC, Meitav Dash Investments Ltd., Cumberland Advisors Inc., Cornerstone Advisory LLC, Tocqueville Asset Management L.P., and Hartline Investment Corp.

Which major investors are buying SPDR S&P Biotech ETF stock?

XBI stock was purchased by a variety of institutional investors in the last quarter, including Kellogg W K Foundation Trust, Bank of Montreal Can, LVM Capital Management Ltd. MI, Stifel Financial Corp, Kerrisdale Advisers LLC, Eqis Capital Management Inc., Evolution Wealth Advisors LLC, and PNC Financial Services Group Inc..

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $116.24.

How big of a company is SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF has a market capitalization of $6.36 billion.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.